Table 2 Prevalence of albuminuria, estimated glomerular filtration rate (eGFR) and stages of CKD stratified by clinical conditions
Variable | Diabetes (n = 120) | Hypertension (n = 65) | Hypertension and diabetes (n = 23) | Total (n = 208) | P-value |
|---|---|---|---|---|---|
uPCR | |||||
<3 mg/mmol | 102 (85.0) | 52 (80) | 7 (30.4) | 161 (77.4) | p < 0.001 |
3–30 mg/mmol | 18 (15.0) | 10 (15.4) | 15 (65.2) | 43 (20.7) | |
>30 mg/mmol | 0 (0.0) | 3 (4.6) | 1 (4.3) | 4 (1.9) | |
eGFR, mL/min/1.73 m2 n (%) | |||||
≥90 | 39 (33) | 16 (25) | 5 (22) | 60 (29) | p < 0.001 |
60–89 | 54 (45) | 39 (60) | 5 (22) | 98 (47) | |
45–59 | 15 (13) | 1 (1.5) | 3 (13) | 19 (9.1) | |
30–44 | 9 (7.5) | 5 (7.7) | 4 (17) | 18 (8.7) | |
15–29 | 3 (2.5) | 4 (6.2) | 6 (26) | 13 (6.2) | |
<15 | 0 0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
CKD n (%) | |||||
Stage 1: eGFR ≥90 + Alb | 1 (0.8) | 1 (1.5) | 1 (4.3) | 3 (1.4) | 0.16 |
Stage 2: eGFR 60–89 + Alb | 4 (3.3) | 3 (4.6) | 3 (13.0) | 10 (4.8) | |
Stage 3a: eGFR 45–59 | 15 (12) | 1 (1.5) | 3 (13.0) | 19 (9.1) | |
Stage 3b: eGFR 30–44 | 9 (7.5) | 5 (7.7) | 4 (17) | 18 (8.7) | |
Stage 4: eGFR15–29 | 3 (2.5) | 4 (6.2) | 6 (26) | 13 (6.3) | |
Stage 5: eGFR < 15 | 0 | 0 | 0 | 0 | |
Total CKD, n (%) | |||||
(Stages 1–5) | 32 (27) | 14 (22) | 17 (74) | 63 (30) | |